Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2021 Q4 2021 Q3, filed 14 Feb, long equity only

Download CSV Download Excel All activity


IQV, IQVIA	4.41%, was 3.28%	Add +8.4%	2,930,756	$282.14	$827M	+227,000	+$179M
BSX, Boston Scientific	3.81%, was 3.08%	Add +20.1%	16,814,581	$42.48	$714M	+2,812,000	+$107M
GOOG, Alphabet	3.54%, was 2.44%	Add +26.9%	228,957	$2,894	$663M	+48,500	+$182M
ARMK, Aramark	3.53%	Reduce −1.9%	17,962,483	$36.85	$662M	−355,173	+$60M
TMO, Thermo Fisher Scientific	3.46%	Reduce −0.7%	972,959	$667.24	$649M	−6,700	+$89M
WAB, Wabtec	3.07%, was 2.60%	Add +5.0%	6,241,151	$92.11	$575M	+296,000	+$62M
HWM, Howmet Aerospace	2.81%, was 1.65%	Add +58.8%	16,531,453	$31.83	$526M	+6,123,453	+$201M
RTX	2.65%, was 2.27%	Add +10.7%	5,775,386	$86.06	$497M	+560,400	+$49M
META, Meta Platforms	2.45%, was 1.83%	Add +28.2%	1,366,545	$336.35	$460M	+300,800	+$98M
MSFT, Microsoft	2.44%	Reduce −10.0%	1,361,278	$336.32	$458M	−151,300	+$31M
BHP Group	2.16%, was 1.63%	Add +6.8%	6,785,000	$59.77	$406M	+431,000	+$83M
NYT, New York Times	2.15%, was 2.03%	Add +2.5%	8,336,258	$48.30	$403M	+200,000	+$1.8M
MA, Mastercard	2.13%, was 1.67%	Add +17.4%	1,113,300	$359.32	$400M	+165,200	+$70M
AON, Aon	1.91%	Reduce −5.5%	1,193,486	$300.56	$359M	−68,829	−$2M
CNC, Centene	1.91%	Reduce −5.1%	4,339,344	$82.40	$358M	−233,531	+$73M
ELV, Anthem	1.87%	Reduce −11.7%	755,060	$463.54	$350M	−99,905	+$31M
SHW, Sherwin-Williams	1.79%	Reduce −1.9%	951,068	$352.16	$335M	−18,800	+$64M
TRU, Transunion	1.76%, was 1.16%	Add +37.3%	2,789,182	$118.58	$331M	+757,200	+$103M
NOW, ServiceNow	1.74%, was 1.56%	Add +1.4%	503,150	$649.11	$327M	+6,850	+$18M
AVGO, Broadcom	1.71%	Reduce −26.1%	481,000	$665.41	$320M	−169,500	+$4.6M
BX, Blackstone	1.65%	Reduce −9.9%	2,395,336	$129.39	$310M	−264,200	+$523K
V, Visa	1.64%, was 1.40%	Add +13.8%	1,414,604	$216.71	$307M	+171,100	+$30M
EFX, Equifax	1.57%, was 1.14%	Add +12.7%	1,005,183	$292.79	$294M	+113,600	+$68M
CRM, Salesforce	1.51%, was 2.17%	Reduce −29.4%	1,113,638	$254.13	$283M	−464,277	−$145M
ABBV, AbbVie	1.16%, was 0.26%	Add +233.8%	1,608,451	$135.40	$218M	+1,126,603	+$166M
ADBE, Adobe	1.14%	New	376,000	$567.06	$213M	+376,000	+$213M
CHTR, Charter Communications	1.10%, was 1.40%	Reduce −17.1%	315,701	$651.97	$206M	−65,300	−$71M
ALNY, Alnylam Pharmaceuticals	1.08%, was 0.78%	Add +46.1%	1,190,028	$169.58	$202M	+375,727	+$48M
BEAM, Beam Therapeutics	0.96%, was 0.76%	Add +31.9%	2,265,045	$79.69	$181M	+547,455	+$31M
EXEL, Exelixis	0.86%, was 1.03%	Reduce −8.3%	8,859,157	$18.28	$162M	−800,555	−$42M
AVTR, Avantor	0.82%, was 0.68%	Add +11.6%	3,642,858	$42.14	$154M	+377,707	+$20M
Horizon Therapeutics Pub	0.80%, was 0.65%	Add +19.1%	1,396,217	$107.76	$150M	+224,043	+$22M
NTRA, Natera	0.73%	Add +13.3%	1,472,715	$93.39	$138M	+172,581	−$7.4M
CVS, CVS Health	0.71%, was 0.10%	Add +447.6%	1,281,456	$103.16	$132M	+1,047,456	+$112M
Laboratory Corporation Amer	0.69%, was 0.51%	Add +16.4%	414,169	$314.21	$130M	+58,298	+$30M
ENTA, Enanta Pharmaceuticals	0.63%	Reduce −21.1%	1,573,829	$74.78	$118M	−421,171	+$4.4M
YMM, Full Truck Alliance	0.63%, was 0.06%	Add +1618.7%	14,007,743	$8.37	$117M	+13,192,743	+$105M
IOVA, Iovance Biotherapeutics	0.62%	Add +13.5%	6,061,973	$19.09	$116M	+721,979	−$16M
AZNN	0.59%, was 0.10%	Add +470.7%	1,906,155	$58.25	$111M	+1,572,155	+$91M
Lufax	0.57%, was 0.51%	Add +32.5%	19,019,399	$5.63	$107M	+4,662,500	+$6.9M
CYTK, Cytokinetics	0.53%	Reduce −20.6%	2,170,342	$45.58	$99M	−562,433	+$1.3M
Catalent	0.52%, was 0.63%	Reduce −17.9%	763,561	$128.03	$98M	−166,638	−$26M
Blueprint Medicines	0.46%, was 0.49%	Reduce −14.0%	811,747	$107.11	$87M	−132,656	−$10M
PCG, PG&E	0.41%	Reduce −13.5%	6,305,142	$12.14	$77M	−986,900	+$6.5M
Sarepta Therapeutics	0.40%, was 0.08%	Add +417.9%	839,009	$90.05	$76M	+677,009	+$61M
Karuna Therapeutics	0.38%, was 0.43%	Reduce −21.4%	550,000	$131.00	$72M	−150,000	−$14M
UTHR, United Therapeutics	0.37%	New	320,760	$216.08	$69M	+320,760	+$69M
RVMD, Revolution Medicines	0.37%	Hold	2,750,000	$25.17	$69M	—	—
PTGX, Protagonist Therapeutics	0.35%	Reduce −19.9%	1,917,134	$34.20	$66M	−474,866	+$23M
BRKR, Bruker	0.33%	New	745,266	$83.91	$63M	+745,266	+$63M
Amyris	0.31%, was 0.82%	Reduce −7.3%	10,859,811	$5.41	$59M	−859,114	−$102M
Imago Biosciences	0.31%	Reduce −7.5%	2,471,313	$23.71	$59M	−200,000	+$5.1M
Atento	0.30%	Hold	2,230,357	$25.53	$57M	—	—
JAZZ, Jazz Pharmaceuticals	0.29%, was 0.38%	Reduce −25.0%	431,021	$127.40	$55M	−143,886	−$20M
Broadmark Realty Cap	0.24%, was 0.25%	Reduce −2.1%	4,850,000	$9.43	$46M	−106,174	−$3.1M
Qiagen	0.24%, was 0.39%	Reduce −44.8%	814,064	$55.58	$45M	−659,784	−$31M
Zogenix	0.24%	Hold	2,766,935	$16.25	$45M	—	—
Zendesk	0.24%	New	430,000	$104.29	$45M	+430,000	+$45M
CRBU, Caribou Biosciences	0.24%	Hold	2,963,448	$15.09	$45M	—	—
FATE, Fate Therapeutics	0.24%, was 0.69%	Reduce −67.2%	757,425	$58.51	$44M	−1,553,973	−$93M
PACB	0.22%	Add +2.7%	2,045,488	$20.46	$42M	+53,238	−$9.1M
AGIO, Agios Pharmaceuticals	0.22%, was 0.19%	Add +53.5%	1,256,578	$32.87	$41M	+437,811	+$3.5M
RGEN, Repligen	0.19%, was 0.13%	Add +49.6%	136,245	$264.84	$36M	+45,175	+$9.8M
BIIB, Biogen	0.19%, was 0.24%	Reduce −13.5%	147,709	$239.92	$35M	−23,150	−$13M
Chemocentryx	0.18%, was 0.03%	Add +142.3%	935,463	$36.41	$34M	+549,463	+$27M
Marblegate Acquisition	0.15%	New	2,970,000	$9.77	$29M	+2,970,000	+$29M
BEKE, KE Holdings	0.15%, was 0.03%	Add +411.7%	1,397,000	$20.12	$28M	+1,124,000	+$23M
Holding	0.15%	Hold	2,809,000	$9.76	$27M	—	—
Exact Sciences	0.13%, was 0.29%	Reduce −46.1%	321,898	$77.83	$25M	−275,700	−$32M
Generation Bio	0.13%	Hold	3,500,000	$7.08	$25M	—	—
Cara Therapeutics	0.13%	Hold	2,000,000	$12.18	$24M	—	—
Austerlitz Acquisition	0.13%, was 0.12%	Add +1.8%	2,500,000	$9.71	$24M	+43,113	−$146K
Berenson Acquisition	0.13%	New	2,475,000	$9.67	$24M	+2,475,000	+$24M
Metals Acquisition	0.13%	New	2,475,000	$9.65	$24M	+2,475,000	+$24M
QTRX, Quanterix	0.12%	Hold	545,000	$42.40	$23M	—	—
Ventyx Biosciences	0.12%	New	1,114,280	$19.86	$22M	+1,114,280	+$22M
GPOR, Gulfport Energy	0.11%, was 0.13%	Reduce −8.0%	296,372	$72.03	$21M	−25,747	−$5.1M
ARWR, Arrowhead Pharmaceuticals	0.11%, was 0.25%	Reduce −59.8%	320,617	$66.30	$21M	−475,961	−$28M
Somalogic	0.11%, was 0.37%	Reduce −69.0%	1,808,907	$11.64	$21M	−4,017,566	−$51M
Holding	0.11%	Hold	1,000,000	$19.72	$20M	—	—
Swiftmerge Acquisition	0.11%	New	1,980,000	$9.94	$20M	+1,980,000	+$20M
Revolution Healthcar Aq	0.10%	Hold	2,000,000	$9.71	$19M	—	—
Holding	0.10%	New	1,900,000	$9.64	$18M	+1,900,000	+$18M
Holding	0.09%	Hold	1,750,000	$9.75	$17M	—	—
Holding	0.09%	Hold	1,732,500	$9.80	$17M	—	—
Ready Capital	0.09%	Reduce −13.5%	1,080,961	$15.63	$17M	−169,265	−$1.1M
Sdcl Edge Acquisition	0.09%	New	1,732,500	$9.74	$17M	+1,732,500	+$17M
Vector Acquisition Corporation II	0.09%, was 0.04%	Add +126.7%	1,700,000	$9.77	$17M	+950,000	+$9.3M
Shelter Acquisition	0.09%	Hold	1,650,000	$9.75	$16M	—	—
Big Sky Growth Partners	0.08%	Hold	1,550,000	$9.71	$15M	—	—
KKR	0.08%	Hold	1,500,000	$9.74	$15M	—	—
Radius Health	0.08%	Hold	2,107,400	$6.92	$15M	—	—
Holding	0.08%	Hold	1,500,000	$9.72	$15M	—	—
Berkeley LTS	0.08%	New	787,327	$18.18	$14M	+787,327	+$14M
Ares Acquisition	0.07%, was 0.05%	Add +42.5%	1,425,000	$9.74	$14M	+425,000	+$4.1M
Humanco Acquisition	0.07%, was 0.03%	Add +176.6%	1,407,749	$9.78	$14M	+898,849	+$8.7M
Disruptive Acquisition	0.07%	Hold	1,400,000	$9.80	$14M	—	—
Ikena Oncology	0.07%, was 0.11%	Reduce −3.2%	1,081,309	$12.54	$14M	−36,040	−$8.8M
Holding	0.07%, was 0.05%	Add +36.0%	1,360,040	$9.95	$14M	+360,040	+$3.7M
Fibrogen	0.07%	Reduce −36.4%	919,117	$14.10	$13M	−527,095	−$1.8M
Holding	0.06%	Hold	1,250,000	$9.73	$12M	—	—
NUVB, Nuvation Bio	0.06%, was 0.11%	Reduce −35.3%	1,430,000	$8.50	$12M	−780,000	−$9.8M
TCV Acquisition	0.06%, was 0.02%	Add +142.3%	1,211,459	$9.86	$12M	+711,459	+$7M
Holding	0.06%, was 0.04%	Add +61.1%	1,208,326	$9.77	$12M	+458,326	+$4.5M
Nightdragon Acquisition	0.06%, was 0.02%	Add +200.0%	1,200,000	$9.75	$12M	+800,000	+$7.8M
Agile Growth	0.06%	Hold	1,200,000	$9.70	$12M	—	—
Gores Holdings VII	0.06%, was 0.04%	Add +53.4%	1,150,162	$9.78	$11M	+400,162	+$3.9M
Holding	0.06%, was 0.04%	Add +49.3%	1,120,102	$9.80	$11M	+370,102	+$3.6M
Gores Metropoulos II	0.06%	Hold	1,100,000	$9.97	$11M	—	—
TPG Pace Beneficial II	0.06%, was 0.04%	Add +48.9%	1,116,833	$9.80	$11M	+366,833	+$3.6M
Tiga Acquisition	0.06%	Hold	1,080,000	$10.13	$11M	—	—
Zealand Pharma A/s	0.06%	Hold	510,000	$21.34	$11M	—	—
Holding	0.05%	Hold	1,000,000	$9.89	$9.9M	—	—
Holding	0.05%	Hold	1,000,000	$9.87	$9.9M	—	—
Cascade Acquisition	0.05%	Hold	990,000	$9.94	$9.8M	—	—
Churchill Capital Corporation VII	0.05%	Hold	1,000,000	$9.83	$9.8M	—	—
Holding	0.05%	Hold	1,000,000	$9.78	$9.8M	—	—
Forum Merger IV	0.05%	Hold	1,000,000	$9.74	$9.7M	—	—
Savara	0.05%	Add +19.3%	7,770,262	$1.24	$9.6M	+1,258,176	+$648K
RCEL, Avita Medical	0.05%	Hold	800,000	$11.98	$9.6M	—	—
Point Biopharma Global	0.05%, was 0.09%	Reduce −25.5%	1,706,329	$5.60	$9.6M	−583,671	−$8.1M
Clever Leaves	0.05%	Add +19.9%	3,049,853	$3.10	$9.5M	+506,086	−$10M
Holding	0.05%	New	900,000	$10.15	$9.1M	+900,000	+$9.1M
Interprivate II Acquisition	0.05%, was 0.02%	Add +120.7%	882,647	$9.70	$8.6M	+482,647	+$4.7M
Exscientia	0.04%	New	425,000	$19.76	$8.4M	+425,000	+$8.4M
Holding	0.04%, was 0.03%	Add +40.5%	843,046	$9.90	$8.3M	+243,046	+$2.5M
RXR Acquisition	0.04%, was 0.03%	Add +42.5%	854,961	$9.75	$8.3M	+254,961	+$2.5M
Holding	0.04%	Add +6.0%	848,184	$9.80	$8.3M	+48,184	+$600K
Holding	0.04%	Add +16.1%	825,100	$9.90	$8.2M	+114,649	+$1.1M
Holding	0.04%	Add +10.8%	835,638	$9.74	$8.1M	+81,738	+$788K
Arya Sciences Acqu Corporation IV	0.04%	Hold	800,000	$9.93	$7.9M	—	—
VCYT, Veracyte	0.04%	Add +3.2%	191,158	$41.20	$7.9M	+5,936	−$728K
Landcadia Holdings IV	0.04%, was 0.02%	Add +60.4%	802,028	$9.74	$7.8M	+302,028	+$2.9M
Holding	0.04%	Hold	800,000	$9.75	$7.8M	—	—
Levere	0.04%	Hold	800,000	$9.74	$7.8M	—	—
Churchill Capital Corporation VI	0.04%, was 0.02%	Add +95.7%	782,767	$9.78	$7.7M	+382,767	+$3.7M
Holding	0.04%	New	775,200	$9.83	$7.6M	+775,200	+$7.6M
Holding	0.04%	New	750,000	$10.03	$7.5M	+750,000	+$7.5M
Holding	0.04%	Hold	750,000	$9.98	$7.5M	—	—
Social Leverage Acquisn	0.04%	Hold	750,000	$9.81	$7.4M	—	—
Holding	0.04%	Hold	750,000	$9.78	$7.3M	—	—
Holding	0.04%	Hold	750,000	$9.76	$7.3M	—	—
Research Alliance Corporation II	0.04%	Hold	750,000	$9.72	$7.3M	—	—
Panacea Acquisition Corporation II	0.04%	Hold	750,000	$9.70	$7.3M	—	—
Pathfinder Acquisition	0.04%	Hold	750,000	$9.70	$7.3M	—	—
Holding	0.04%	Hold	745,000	$9.69	$7.2M	—	—
Gores Holdings VIII	0.04%, was 0.02%	Add +73.2%	692,810	$10.20	$7.1M	+292,810	+$3.1M
Dariohealth	0.04%	Hold	540,000	$12.97	$7M	—	—
Corsair Partnering	0.04%	Hold	700,000	$9.76	$6.8M	—	—
Holding	0.04%	Hold	700,000	$9.75	$6.8M	—	—
Khosla Ventures Acquisition	0.04%	Hold	700,000	$9.70	$6.8M	—	—
Theseus Pharmaceuticals	0.04%	New	523,979	$12.68	$6.6M	+523,979	+$6.6M
Rocket Internet Grwt Oprt	0.03%, was 0.02%	Add +29.6%	647,945	$9.80	$6.4M	+147,945	+$1.5M
Better Therapeutics	0.03%	New	1,350,000	$4.65	$6.3M	+1,350,000	+$6.3M
Holding	0.03%	Hold	600,000	$10.25	$6.2M	—	—
RCF Acquisition	0.03%	New	600,000	$10.10	$6.1M	+600,000	+$6.1M
Holding	0.03%	Hold	600,000	$9.76	$5.9M	—	—
Finserv Acquisition Corporation II	0.03%	Hold	600,000	$9.72	$5.8M	—	—
Blue Whale Acquisition	0.03%	New	575,000	$9.69	$5.6M	+575,000	+$5.6M
Slam	0.03%	Add +709.0%	570,396	$9.75	$5.6M	+499,888	+$4.9M
ANNX, Annexon	0.03%, was 0.11%	Reduce −60.4%	457,764	$11.49	$5.3M	−699,497	−$16M
COGT, Cogent Biosciences	0.03%	Hold	600,000	$8.58	$5.1M	—	—
G Squared Ascend	0.03%	Hold	500,000	$9.88	$4.9M	—	—
Ftac Hera Acquisition	0.03%	Hold	500,000	$9.77	$4.9M	—	—
Holding	0.03%, was 0.02%	Add +0.4%	502,001	$9.68	$4.9M	+2,001	+$14K
Holding	0.03%	Hold	500,000	$9.71	$4.9M	—	—
Holding	0.03%, was 0.01%	Add +93.9%	484,709	$9.77	$4.7M	+234,709	+$2.3M
Holding	0.02%, was 0.01%	Add +81.0%	452,519	$9.91	$4.5M	+202,519	+$2M
Scion Tech Growth II	0.02%	Hold	450,000	$9.73	$4.4M	—	—
LDH Growth	0.02%, was 0.01%	Add +191.1%	436,702	$9.82	$4.3M	+286,702	+$2.8M
SVF Investment	0.02%, was 0.01%	Add +70.0%	425,000	$10.04	$4.3M	+175,000	+$1.8M
Holding	0.02%	Hold	425,000	$9.81	$4.2M	—	—
Lamf Global Ventures	0.02%	New	400,000	$10.04	$4M	+400,000	+$4M
Holding	0.02%	Hold	400,000	$9.91	$4M	—	—
Holding	0.02%	Hold	400,000	$9.90	$4M	—	—
Holding	0.02%	Hold	810,500	$4.84	$3.9M	—	—
Lianbio	0.02%	New	600,000	$6.16	$3.7M	+600,000	+$3.7M
Holding	0.02%	New	350,000	$10.15	$3.6M	+350,000	+$3.6M
Uta Acquisition	0.02%	New	350,000	$10.05	$3.5M	+350,000	+$3.5M
TNGX, Tango Therapeutics	0.02%	Hold	300,000	$10.94	$3.3M	—	—
CMPX, Compass Therapeutics	0.02%	New	1,000,000	$3.17	$3.2M	+1,000,000	+$3.2M
Holding	0.02%	New	300,000	$10.11	$3M	+300,000	+$3M
Holding	0.02%	Hold	304,698	$9.84	$3M	—	—
Lazard Growth Acquisition	0.02%	Hold	300,000	$9.73	$2.9M	—	—
Avrobio	0.02%	Hold	740,000	$3.85	$2.8M	—	—
Holding	0.01%	New	86,454	$29.28	$2.5M	+86,454	+$2.5M
Surface Oncology	0.01%, was 0.04%	Reduce −48.0%	520,021	$4.78	$2.5M	−479,979	−$5.1M
Broadscale Acquisition	0.01%	New	250,000	$9.94	$2.5M	+250,000	+$2.5M
Live Oak Mobility Acquisi	0.01%	Hold	250,000	$9.77	$2.4M	—	—
Hudson Executive Inves III	0.01%	Hold	250,000	$9.72	$2.4M	—	—
Arctos Northstar Acquis	0.01%	Hold	200,000	$9.74	$1.9M	—	—
Holding	0.01%	Reduce −11.2%	177,580	$10.29	$1.8M	−22,420	−$117K
Priveterra Acquisition	0.01%	Hold	150,000	$9.72	$1.5M	—	—
Music Acquisition	0.01%	Hold	125,000	$9.76	$1.2M	—	—
Crypto 1 Acquisition	0.01%	New	100,000	$10.10	$1M	+100,000	+$1M
NTRS, Northern Trust	0.01%	Hold	100,000	$9.75	$975K	—	—
NTRS, Northern Trust	0.01%	Hold	100,000	$9.74	$974K	—	—
OKLO, Altc Acquisition	0.01%	New	98,300	$9.85	$968K	+98,300	+$968K
GRFS, Grifols	0.00%	Hold	53,133	$11.22	$596K	—	—
Holding	0.00%	Hold	60,053	$9.87	$593K	—	—
Holding	0.00%	Hold	85,838	$6.05	$519K	—	—
Holding	0.00%	Hold	130,000	$2.10	$273K	—	—

Showing top 50 of 202 by value

Exits / last held

Gone since 2021 Q3, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
TMUS, T-Mobile US	2.98%	Exit	$127.76	$588M	−4,599,011	−$588M
Holding	1.89%	Exit	$172.10	$373M	−2,164,663	−$373M
WTW, Willis Towers Watson	1.62%	Exit	$232.46	$319M	−1,373,000	−$319M
HLT, Hilton	1.40%	Exit	$132.11	$275M	−2,085,077	−$275M
FIS, Fidelity National Information Services	1.35%	Exit	$121.68	$267M	−2,192,172	−$267M
Holding	0.90%	Exit	$40.56	$177M	−4,361,050	−$177M
Playa Hotels & Resorts	0.35%	Exit	$8.29	$69M	−8,352,553	−$69M
BABA, Alibaba	0.32%	Exit	$148.05	$62M	−421,400	−$62M
Ihs Markit	0.30%	Exit	$116.62	$60M	−514,900	−$60M
Mirati Therapeutics	0.21%	Exit	$176.91	$42M	−238,718	−$42M
Arena Pharmaceuticals	0.20%	Exit	$59.55	$39M	−656,548	−$39M
NEO, Neogenomics	0.13%	Exit	$48.24	$26M	−529,839	−$26M
Metals Acquisition	0.12%	Exit	$9.91	$25M	−2,475,000	−$25M
Berenson Acquisition	0.12%	Exit	$9.86	$24M	−2,475,000	−$24M
Holding	0.10%	Exit	$10.05	$20M	−2,000,000	−$20M
Holding	0.10%	Exit	$10.18	$19M	−1,900,787	−$19M
DKNG, Draftkings	0.10%	Exit	$48.16	$19M	−390,000	−$19M
Holding	0.10%	Exit	$9.88	$19M	−1,900,000	−$19M
FIVN, Five9	0.09%	Exit	$159.74	$19M	−116,000	−$19M
NVAX, Novavax	0.09%	Exit	$207.32	$17M	−83,713	−$17M
FS Development Corporation II	0.05%	Exit	$9.95	$10M	−1,000,000	−$10M
QURE, Uniqure	0.05%	Exit	$32.01	$9.6M	−300,000	−$9.6M
QSI, Quantum Si	0.04%	Exit	$8.34	$8.3M	−1,000,000	−$8.3M
Holding	0.04%	Exit	$10.20	$7.9M	−775,200	−$7.9M
Holding	0.04%	Exit	$9.93	$7.4M	−750,000	−$7.4M
CM Life Sciences III	0.04%	Exit	$9.92	$7.4M	−750,000	−$7.4M
Blue Whale Acquisition	0.03%	Exit	$10.01	$5.8M	−575,000	−$5.8M
Nextgen Acquisition Corporation II	0.03%	Exit	$9.91	$5.5M	−550,914	−$5.5M
BCAB, Bioatla	0.03%	Exit	$29.44	$5.3M	−180,000	−$5.3M
TPG Pace Solutions	0.02%	Exit	$10.05	$3.5M	−350,000	−$3.5M
Achilles Therapeutics	0.02%	Exit	$7.79	$3.5M	−450,000	−$3.5M
NTRS, Northern Trust	0.01%	Exit	$9.93	$2.8M	−278,026	−$2.8M
Orchard Therapeutics	0.01%	Exit	$2.30	$1.5M	−665,200	−$1.5M
CF Acquisition Corporation VI	—	Exit	$9.71	$971K	−100,000	−$971K
Alpha Capital Acquisition	—	Exit	$9.72	$774K	−79,598	−$774K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov